Search clinical trials for: Age-Related Macular Degeneration (AMD)

Total 4634 results

i-Lumen Scientific, Inc.

Recruiting

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) (i-SIGHT)

Age-Related Macular Degeneration | Dry Age-related Macular Degeneration | Nonexudative Age-related Macular Degeneration

United States
University Hospital, Bordeaux
Laboratoires Thea

Completed

Lutein Influence on Macula of Persons Issued From Amd Parents (LIMPIA)

Persons Issued From Amd Parents

France
i-Lumen Scientific, Inc.

Withdrawn

Microcurrent Stimulation for Dry Age-related Macular Degeneration (i-SIGHT)

Dry Age-related Macular Degeneration
Novartis Pharmaceuticals

Completed

A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

Neovascular Age-related Macular Degeneration

Japan
Sequenom, Inc.

Completed

Genetic Load and Phenotype in Aggressive AMD (RPED Genetics)

Age-related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Foresee Home for Monitoring Age Related Macular Degeneration (AMD) (Foresee Home)

Age Related Macular Degeneration

Israel
Novartis Pharmaceuticals

Completed

Canadian Treat and Extend Analysis Trial With Ranibizumab (CAN-TREAT)

wetAMD

Canada
Notal Vision Ltd.

Completed

Sensitivity and Specificity of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

Israel
The New York Eye & Ear Infirmary
iHealthScreen Inc

Recruiting

Telemedicine in Age-Related Macular Degeneration

Age Related Macular Degeneration

United States
Oraya Therapeutics, Inc.

Completed

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD (INTREPID)

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | AMD | Wet AMD | Wet Age-Related Macular Degeneration

United Kingdom, Czech Republic, Austria, Germany, Italy
Notal Vision Ltd.

Completed

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device (AREDS)

Age Related Macular Degeneration

United States
University of Applied Sciences Upper Austria
Krankenhaus der Barmherzigen Schwestern Ried

Unknown

The Effects of Regular Eye-training With a Mobile Device on Adult Patients With AMD (ETAMD)

AMD

Austria
Alcon Research

Completed

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

AMD

United States
Alcon Research

Completed

A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration

AMD
Nantes University Hospital
Rennes University Hospital

Not yet recruiting

Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD. (FAR-WEST)

AMD

France
Notal Vision Ltd.

Completed

Retinal Imaging Using NOTAL-OCT V2.5

AMD

Israel
Oraya Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Macular Degeneration | Age-related Macular Degeneration | AMD | Wet AMD | Wet Age-related Macular Degeneration

United Kingdom, Italy
Retina Research Foundation

Completed

Scotoma Reduction in AMD Patients Treated With Ranibizumab (SALVAGE)

Macular Degeneration

United States
NYU Langone Health

Completed

A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

Glaucoma | Age-Related Macular Degeneration | Diabetic Retinopathy | Visual Impairment

United States
AbbVie

Recruiting

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

CNV | AMD | nAMD | Wet Age-related Macular Degeneration | wAMD | WetAMD

United States, Puerto Rico, Canada
AbbVie

Recruiting

Pivotal 1 Study of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)

CNV | AMD | nAMD | Wet AMD | Wet Age-related Macular Degeneration | wAMD

United States
Icahn School of Medicine at Mount Sinai
University of California, Los Angeles; National Eye Institute (NEI)

Recruiting

Snapshot Camera for AMD

Age Related Macular Degeneration

United States
Oraya Therapeutics, Inc.

Unknown

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (ENDEAVOUR)

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | Wet Macular Degeneration

United Kingdom
Notal Vision Ltd.

Completed

Retinal Imaging Using NOTAL-OCT V3.0

AMD | DR

Israel
Retina Institute of Hawaii

Completed

Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis

Wet AMD

United States
Lucy A Wibbenmeyer
Medtronic - MITG

Completed

Kerlix Gauze Study in a Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients

Burns | Wounds

United States
Alcon Research

Terminated

Anecortave Acetate Risk Reduction Trial (AART)

AMD

India
National Eye Institute (NEI)

Completed

AMD Phenotype and Genotype Study

Age-Related Macular Degeneration | AMD

United States, Germany
Carl Zeiss Meditec, Inc.
DataMed Devices Inc.

Completed

Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation

Dry AMD With Macular Drusen

United States
Tyrogenex
International Drug Development Institute; SynteractHCR

Terminated

X-82 to Treat Age-related Macular Degeneration

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Diseases | Age-Related Macular Degeneration (AMD) | Exudative Age-related Macular Degeneration | AMD | Macular Degeneration, Age-related, 10

United States
Osaka University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Age Related Macular Degeneration | Neovascular Maculopathy

Japan
National Eye Institute (NEI)

Completed

Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study

AMD | Age- Related Macular Degeneration

United States
StemCells, Inc.

Terminated

Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Age-Related Macular Degeneration | Geographic Atrophy

United States
Notal Vision Ltd.

Completed

Age-Related Macular Degeneration (AMD) - Usability Study (AMD)

Age Related Macular Degeneration
Youxin Chen

Recruiting

A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Neovascular Age-related Macular Degeneration

China
Skyline Therapeutics (US) Inc.

Recruiting

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Neovascular Age-related Macular Degeneration

China, United States
AbbVie
AbbVie

Recruiting

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)

Neovascular Age-Related Macular Degeneration (nAMD)

United States
Novartis Pharmaceuticals

Completed

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

Age-related Macular Degeneration (AMD)

United States
Notal Vision Ltd.

Completed

Sensitivity of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration | Choroidal Neovascularization

United States
Notal Vision Ltd.

Completed

Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging

AMD Population - Intermediate or Advanced AMD | DR Population- With or Without Diabetic Macular Edema

Israel
Alcon Research

Terminated

Anecortave Acetate Risk-Reduction Trial (AART)

Dry AMD

United States
Eyetech Pharmaceuticals
Pfizer

Unknown

A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

Age-Related Macular Degeneration (AMD)

United States
MidAtlantic Retina
Regeneron Pharmaceuticals

Completed

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration (ATLAS)

Age-Related Macular Degeneration | Macular Degeneration

United States
YD Global Life Science Co., Ltd.

Unknown

The Study to YD312 Tablet in Patients With Diabetic Macular Edema

Diabetic Macular Edema(DME)

United States, Korea, Republic of
CoMentis

Terminated

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Macular Degeneration

Brazil, Mexico, Czech Republic, Poland, Russian Federation, Ukraine
Hoffmann-La Roche

Withdrawn

A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration (Diagrid)

Neovascular Age-Related Macular Degeneration

Denmark, Argentina, Hong Kong, Thailand, Portugal, Greece, Spain
Novartis Pharmaceuticals

Completed

Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Degeneration | Retinal Diseases | Wet Macular Degeneration

United States, Puerto Rico
Ophthotech Corporation

Completed

ARC1905 (ANTI-C5 APTAMER) Given Either In Combination Therapy With Lucentis® 0.5 mg/Eye In Subjects With Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Ophthotech Corporation

Completed

A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Genentech, Inc.

Completed

Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

Age-Related Maculopathy

Search clinical trials for: Age-Related Macular Degeneration (AMD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations